Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)

Today in trading, Briacell Therapeutics Corp shares closed at $0.98 after opening the day at $1.01. It traded at a low of $0.97 to a high of $1.01.

Shares dipped -4.85 percent from the previous day's close of $1.03.

During the day across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

Trading volume was 7,280 on 17 total trades, while having an average volume of 3,090 over 5 days.

The TSX overall saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, the shares have shrunken -89.14 percent in the last 12 months, while in 2024, they have plummeted -87.44%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $18.83 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..